What are the options for non-small-cell lung cancer patients post second-line therapy?

Future Oncol. 2015;11(17):2379-82. doi: 10.2217/FON.15.159. Epub 2015 Aug 13.

Authors

Diego Luigi Cortinovis¹, Stefania Canova¹, Paolo Bidoli¹

Affiliation

¹ Department of Oncology, San Gerardo Hospital, Monza, Via Pergolesi 33, 20900, Monza, Italy.

PMID: 26270000
DOI: 10.2217/FON.15.159

No abstract available

Keywords: NSCLC; clinical trials; precision medicine; third-line therapy.

Publication types

Review

MeSH terms

Carcinoma, Non-Small-Cell Lung / etiology
Carcinoma, Non-Small-Cell Lung / therapy*
Humans
Lung Neoplasms / therapy*
Molecular Targeted Therapy
Retreatment